MMEN.CN Stock Surges 33% on CNQ Exchange Today

By Huzaifa Zahoor

April 29, 2026

4 min read

Share with:

preferred News SourceSelectMeykaasyourpreferredNewsSource

Key Points

MMEN.CN stock surges 33% to C$0.02 on elevated trading volume

MedMen Enterprises faces negative earnings and weak cash flow metrics

Meyka AI rates stock C+ with HOLD recommendation

Company operates 19 cannabis retail stores across five US states

MMEN.CN stock delivered a strong 33% gain today, climbing to C$0.02 on the Canadian CNQ exchange. MedMen Enterprises Inc., a cannabis retailer operating 19 stores across California, Nevada, Illinois, Arizona, and Massachusetts, saw trading volume spike to 189,038 shares—30% above its average. The Los Angeles-based company trades with a market cap of C$27.7 million and continues to operate under CEO Melony Valleau. While the stock remains deeply underwater from its year high of C$0.05, today’s momentum reflects renewed investor interest in the struggling retailer.

MMEN.CN Stock Price Action and Market Movement

MMEN.CN stock opened at C$0.015 and climbed to its daily high of C$0.02, marking the 33% intraday surge. The stock’s 50-day moving average sits at C$0.0231, while the 200-day average stands at C$0.02665, suggesting the current price trades below both key technical levels. Year-to-date performance remains challenging, with the stock down 55.6% over the past year and 94.3% over three years. Despite today’s bounce, MMEN.CN remains near its 52-week low of C$0.015, reflecting the company’s ongoing financial struggles in the competitive cannabis retail sector.

Financial Metrics and Profitability Concerns

MedMen Enterprises faces significant profitability headwinds. The company reports a negative EPS of -C$0.15 and a negative PE ratio, indicating ongoing losses. Revenue per share stands at just C$0.122, while net income per share is -C$0.144. The company’s gross profit margin of 49.5% shows decent product markup, but operating margins of -43.5% reveal heavy overhead costs consuming profits. With a current ratio of 0.49, the company’s liquidity position remains strained, suggesting potential cash flow challenges ahead. Track MMEN.CN on Meyka for real-time updates on these critical metrics.

Market Sentiment and Trading Activity

Today’s trading activity shows elevated investor engagement with 189,038 shares exchanging hands, representing a relative volume of 1.30 compared to the 145,639-share average. This 30% volume surge above normal levels indicates renewed attention on the stock, though it remains unclear whether this reflects institutional accumulation or retail speculation. The stock’s recovery from its daily low of C$0.015 suggests some buying support at lower levels. However, the company’s weak fundamentals and negative cash flow metrics suggest caution is warranted for new investors considering entry points.

Meyka AI Stock Grade and Outlook

Meyka AI rates MMEN.CN with a grade of C+, suggesting a HOLD recommendation. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. The score of 56.88 reflects mixed signals: while the cannabis retail sector shows potential, MedMen’s execution challenges and negative profitability metrics weigh heavily. The company’s debt-to-equity ratio of 2.61 indicates aggressive leverage, raising concerns about financial stability. These grades are not guaranteed and we are not financial advisors. Investors should conduct thorough due diligence before making decisions.

Final Thoughts

MMEN.CN stock’s 33% surge to C$0.02 today reflects short-term trading momentum rather than fundamental improvement. While the cannabis retailer operates across five states with established brand recognition, its negative earnings, weak cash flow, and high debt burden remain serious concerns. The stock’s recovery from its 52-week low suggests some investors see value, but the company must demonstrate profitability and operational efficiency to justify sustained investment. With a Meyka AI grade of C+ and HOLD recommendation, cautious investors should monitor quarterly earnings and cash flow trends before committing capital to this volatile stock.

FAQs

Why did MMEN.CN stock jump 33% today?

MMEN.CN surged 33% to C$0.02 on elevated trading volume of 189,038 shares, 30% above average. The exact catalyst remains unclear, but the move reflects renewed investor interest in the cannabis retailer after trading near 52-week lows.

What is MedMen Enterprises’ current financial health?

MedMen faces profitability challenges with negative EPS of -C$0.15 and negative operating margins of -43.5%. The company’s current ratio of 0.49 and debt-to-equity of 2.61 indicate liquidity and leverage concerns requiring close monitoring.

Is MMEN.CN a good investment at C$0.02?

Meyka AI rates MMEN.CN as C+ with a HOLD recommendation. While the stock trades near 52-week lows, fundamental weaknesses including negative cash flow and high debt suggest caution. Conduct thorough research before investing.

What is MMEN.CN’s market cap and share count?

MMEN.CN has a market cap of C$27.7 million with 1.38 billion shares outstanding. The large share count and small market cap reflect the company’s diminished valuation in the cannabis retail sector.

How has MMEN.CN performed over the past year?

MMEN.CN is down 55.6% over one year, 94.3% over three years, and 99.5% over five years. The stock’s long-term decline reflects persistent operational and profitability challenges in the competitive cannabis market.

Disclaimer:
Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.